These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 22171994

  • 1. IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma.
    Gu FM, Li QL, Gao Q, Jiang JH, Zhu K, Huang XY, Pan JF, Yan J, Hu JH, Wang Z, Dai Z, Fan J, Zhou J.
    Mol Cancer; 2011 Dec 15; 10():150. PubMed ID: 22171994
    [Abstract] [Full Text] [Related]

  • 2. IL-17 Activates the IL-6/STAT3 Signal Pathway in the Proliferation of Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Hu Z, Luo D, Wang D, Ma L, Zhao Y, Li L.
    Cell Physiol Biochem; 2017 Dec 15; 43(6):2379-2390. PubMed ID: 29073625
    [Abstract] [Full Text] [Related]

  • 3. Cantharidin treatment inhibits hepatocellular carcinoma development by regulating the JAK2/STAT3 and PI3K/Akt pathways in an EphB4-dependent manner.
    Zhu M, Shi X, Gong Z, Su Q, Yu R, Wang B, Yang T, Dai B, Zhan Y, Zhang D, Zhang Y.
    Pharmacol Res; 2020 Aug 15; 158():104868. PubMed ID: 32407961
    [Abstract] [Full Text] [Related]

  • 4. IL-17A promotes the invasion-metastasis cascade via the AKT pathway in hepatocellular carcinoma.
    Xu QG, Yu J, Guo XG, Hou GJ, Yuan SX, Yang Y, Yang Y, Liu H, Pan ZY, Yang F, Gu FM, Zhou WP.
    Mol Oncol; 2018 Jun 15; 12(6):936-952. PubMed ID: 29689643
    [Abstract] [Full Text] [Related]

  • 5. IL-6/STAT3 axis initiated CAFs via up-regulating TIMP-1 which was attenuated by acetylation of STAT3 induced by PCAF in HCC microenvironment.
    Zheng X, Xu M, Yao B, Wang C, Jia Y, Liu Q.
    Cell Signal; 2016 Sep 15; 28(9):1314-1324. PubMed ID: 27297362
    [Abstract] [Full Text] [Related]

  • 6. NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL-6/JAK2/STAT3 pathway activation.
    Kang JH, Li MJ, Luan PP, Jiang DK, Chen YW, Xu X, Yu Q, Xu YW, Su Q, Peng WH, Jian WX.
    Cell Biol Int; 2020 Oct 15; 44(10):2053-2064. PubMed ID: 32584509
    [Abstract] [Full Text] [Related]

  • 7. Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3.
    Subramaniam A, Shanmugam MK, Ong TH, Li F, Perumal E, Chen L, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Hui KM, Sethi G.
    Br J Pharmacol; 2013 Oct 15; 170(4):807-21. PubMed ID: 23848338
    [Abstract] [Full Text] [Related]

  • 8. Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3.
    Gu FM, Li QL, Gao Q, Jiang JH, Huang XY, Pan JF, Fan J, Zhou J.
    World J Gastroenterol; 2011 Sep 14; 17(34):3922-32. PubMed ID: 22025881
    [Abstract] [Full Text] [Related]

  • 9. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
    Zhao H, Guo Y, Li S, Han R, Ying J, Zhu H, Wang Y, Yin L, Han Y, Sun L, Wang Z, Lin Q, Bi X, Jiao Y, Jia H, Zhao J, Huang Z, Li Z, Zhou J, Song W, Meng K, Cai J.
    Oncotarget; 2015 Oct 13; 6(31):31927-43. PubMed ID: 26376676
    [Abstract] [Full Text] [Related]

  • 10. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma.
    Pei T, Meng Q, Han J, Sun H, Li L, Song R, Sun B, Pan S, Liang D, Liu L.
    Oncotarget; 2016 Jul 12; 7(28):43475-43491. PubMed ID: 27259268
    [Abstract] [Full Text] [Related]

  • 11. Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells.
    Liu Y, Liu A, Li H, Li C, Lin J.
    Cancer Prev Res (Phila); 2011 Aug 12; 4(8):1296-305. PubMed ID: 21490132
    [Abstract] [Full Text] [Related]

  • 12. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
    Zhao Z, Song J, Tang B, Fang S, Zhang D, Zheng L, Wu F, Gao Y, Chen C, Hu X, Weng Q, Yang Y, Tu J, Ji J.
    J Exp Clin Cancer Res; 2020 Nov 25; 39(1):259. PubMed ID: 33234142
    [Abstract] [Full Text] [Related]

  • 13. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
    Ding H, Zhang X, Su Y, Jia C, Dai C.
    Cell Mol Biol Lett; 2020 Nov 25; 25():8. PubMed ID: 32123532
    [Abstract] [Full Text] [Related]

  • 14. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD, Sun XJ, Yin JJ, Yin M, Wang W, Nie ZQ, Xu J.
    Biomed Pharmacother; 2018 Oct 25; 106():134-141. PubMed ID: 29957463
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.
    Huang W, Chen Z, Zhang L, Tian D, Wang D, Fan D, Wu K, Xia L.
    Gastroenterology; 2015 Oct 25; 149(4):1053-67.e14. PubMed ID: 26065367
    [Abstract] [Full Text] [Related]

  • 16. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
    Lai SC, Su YT, Chi CC, Kuo YC, Lee KF, Wu YC, Lan PC, Yang MH, Chang TS, Huang YH.
    J Exp Clin Cancer Res; 2019 Nov 26; 38(1):474. PubMed ID: 31771617
    [Abstract] [Full Text] [Related]

  • 17. Insulin-Like Growth Factor 1 Receptor Drives Hepatocellular Carcinoma Growth and Invasion by Activating Stat3-Midkine-Stat3 Loop.
    Bie C, Chen Y, Tang H, Li Q, Zhong L, Peng X, Shi Y, Lin J, Lai J, Wu S, Tang S.
    Dig Dis Sci; 2022 Feb 26; 67(2):569-584. PubMed ID: 33559791
    [Abstract] [Full Text] [Related]

  • 18. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
    Kim MS, Lee WS, Jeong J, Kim SJ, Jin W.
    Oncotarget; 2015 Nov 24; 6(37):40158-71. PubMed ID: 26515594
    [Abstract] [Full Text] [Related]

  • 19. LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway.
    Li SJ, Sui MH, Sun ZX, Zhang WW.
    Eur Rev Med Pharmacol Sci; 2019 Feb 24; 23(3):1038-1046. PubMed ID: 30779070
    [Abstract] [Full Text] [Related]

  • 20. ANGPTL1 Interacts with Integrin α1β1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling.
    Yan Q, Jiang L, Liu M, Yu D, Zhang Y, Li Y, Fang S, Li Y, Zhu YH, Yuan YF, Guan XY.
    Cancer Res; 2017 Nov 01; 77(21):5831-5845. PubMed ID: 28904065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.